RenovoRx Elevates Leesa Gentry to Chief Clinical Officer

Friday, 8 March 2024, 21:33

RenovoRx, a prominent medical technology firm, has appointed Leesa Gentry as the new Chief Clinical Officer. The strategic move signals the company's commitment to innovation and market expansion.
LivaRava Finance Meta Image
RenovoRx Elevates Leesa Gentry to Chief Clinical Officer

RenovoRx Promotes Leesa Gentry to Chief Clinical Officer

RenovoRx, a leading medical technology company, recently announced the promotion of Leesa Gentry as its Chief Clinical Officer. This key leadership change underlines the company's focus on innovation and market growth.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe